Design of ultrasensitive chemiluminescence detection of lysozyme in cancer cells based on nicking endonuclease signal amplification technology

Biosensors & Bioelectronics
Xu HunWei Wang

Abstract

Detection of protein using aptamer has been based on recognition between target molecules and aptamer in a 1:1 stoichiometric ratio. The stoichiometric recognition, however, puts an intrinsic limitation on detection sensitivity, because one target molecule produces only one signal probe. Here a novel protein assay strategy was constructed by using cleavage of nicking endonuclease to allow for the sensitive and selective detection of lysozyme. In this strategy, detection signal is amplified through lysozyme-aptamer recognition and nicking endonuclease cleavage, by which one lysozyme produces many signal probes, and nanoparticles chemiluminescence probes (nanoparticles CL probes). Signal amplification brought about significant increase in the sensitivity of lysozyme detection. The detection signals are proportional to the concentration of lysozyme. This nicking endonuclease signal amplification system provides a detection limit of 2.0 × 10(-13)M, which also exhibits a good selectivity for lysozyme detection. Sample assays of lysozyme in K562 cells and B lymphoma cells confirm the reliability and practicality of the protocol, which reveal a good prospect of this platform for biological sample analysis.

Citations

May 15, 2013·The Analyst·Alina VasilescuSimona Carmen Litescu
Mar 18, 2016·The Protein Journal·Maryam Tabarzad, Marzieh Jafari
Sep 6, 2012·Biosensors & Bioelectronics·Cui QiDihua Shangguan
Aug 8, 2015·Chemical Communications : Chem Comm·Xiaomeng WangShusheng Zhang
Sep 10, 2013·Chemical Communications : Chem Comm·Dongli LiaoCong Yu
Aug 14, 2021·Analytical Biochemistry·Faezeh TaghaviSeyed Mohammad Taghdisi
Oct 15, 2014·Analytical Chemistry·Feng LiX Chris Le

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.